FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne Simon

Research Profile

Disorders

Living Beings

HIV-1

Physiology

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Marc Wirden; Manuela Bonmarchand; Vincent Calvez; Slim Fourati; Christine Katlama; Nadine Ktorza; Luminita Schneider; Anne Simon; Cathia Soulié; Roland Tubiana; Marc-Antoine Valantin; Anne-Geneviève Marcelin
Pitfalls of HIV genotypic tropism testing after treatment interruption.
Anne-Geneviève Marcelin; Anne Simon; Marc-Antoine Valantin; Marc Wirden; Patrick Yeni; Charlotte Charpentier; Diane Descamps; Christine Katlama; Roland Landman; Camille Aubron-Olivier; Vincent Calvez
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
Sawsan Harfouch; Zineb Ouazene; Assia Samri; Anne Simon; Laurence Slama; Ioannis Theodorou; Vincent Thibault; Marc-Antoine Valantin; Brigitte Autran; Stéphanie Dominguez; Marguerite Guiguet
Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne Simon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marc Wirden; Manuela Bonmarchand; Vincent Calvez; Slim Fourati; Christine Katlama; Nadine Ktorza; Luminita Schneider; Anne Simon; Cathia Soulié; Roland Tubiana; Marc-Antoine Valantin; Anne-Geneviève Marcelin
Pitfalls of HIV genotypic tropism testing after treatment interruption.
The Journal of antimicrobial chemotherapy 2013;68(1):188-9.
2012: Anne-Geneviève Marcelin; Anne Simon; Marc-Antoine Valantin; Marc Wirden; Patrick Yeni; Charlotte Charpentier; Diane Descamps; Christine Katlama; Roland Landman; Camille Aubron-Olivier; Vincent Calvez
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
The Journal of antimicrobial chemotherapy 2012;67(6):1475-8.
2012: Sawsan Harfouch; Zineb Ouazene; Assia Samri; Anne Simon; Laurence Slama; Ioannis Theodorou; Vincent Thibault; Marc-Antoine Valantin; Brigitte Autran; Stéphanie Dominguez; Marguerite Guiguet
Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection.
Journal of hepatology 2012;56(6):1259-68.
2012: Maude Guillot-Delost; Stéphane Kerbrat; David Klatzmann; Sabine Le Gouvello; Claude Baillou; François Berrehar; Nathalie Chaput; Mustapha Cheraï; Yves Levy; Samy Louafi; Mariana Mesel-Lemoine; Anne Simon; Laurence Weiss; François M Lemoine
Human CD90 identifies Th17/Tc17 T cell subsets that are depleted in HIV-infected patients.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(3):981-91.
2012: Ruxandra Calin; Rachid Agher; Luc Paris; Gilles Peytavin; Luminita Schneider; Anne Simon; Roland Tubiana; Marc-Antoine Valantin; Marc Wirden; Christine Katlama
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy.
Antiviral therapy 2012;17(8):1601-4.
2011: Damien Carrel; Michèle Darmon; Michel B Emerit; Michel Hamon; Christophe Leterrier; Isabelle Rivals; Anne Simon; Marc Biard; Zsolt Lenkei
Axonal targeting of the 5-HT1B serotonin receptor relies on structure-specific constitutive activation.
Traffic (Copenhagen, Denmark) 2011;12(11):1501-20.
2011: Victor Appay; Brigitte Autran; Dominique Costagliola; Steven G Deeks; Solène Fastenackels; Beatrix Grubeck-Loebenstein; Amélie Guihot; Peter W Hunt; Christine Katlama; Michael Keller; Olivier Lambotte; Luminita Schneider; Anne Simon; Hocine Ait Mohand; Delphine Sauce
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.
AIDS (London, England) 2011;25(15):1813-22.
2011: Marc Wirden; Zaina Ait-Arkoub; Ana Canestri; S Fourati; Christine Katlama; Anne-Geneviève Marcelin; Anne Simon; C Soulie; M Thevenin; Roland Tubiana; Vincent Calvez
Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations.
Journal of clinical microbiology 2011;49(7):2700-2.
2011: Delphine Sauce; Martin Larsen; Solène Fastenackels; Michèle Pauchard; Hocine Ait Mohand; Luminita Schneider; Amélie Guihot; Faroudy Boufassa; John Zaunders; Malika Iguertsira; Michelle Bailey; Guy Gorochov; Claudine Duvivier; Guislaine Carcelain; Anthony D Kelleher; Anne Simon; Laurence Meyer; Dominique Costagliola; Steven G Deeks; Olivier Lambotte; Brigitte Autran; Peter W Hunt; Christine Katlama; Victor Appay
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.
Blood 2011;117(19):5142-51.
2011: Marc Wirden; Cathia Soulie; Marc-Antoine Valantin; Slim Fourati; Anne Simon; Sidonie Lambert-Niclot; Manuela Bonmarchand; Cyril Clavel-Osorio; Anne-Geneviève Marcelin; Christine Katlama; Vincent Calvez
Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia.
The Journal of antimicrobial chemotherapy 2011;66(4):709-12.
2011: Stéphanie Haïm-Boukobza; Laurence Morand-Joubert; Philippe Flandre; Nadia Valin; Slim Fourati; Sophie Sayon; Marc Lavignon; Anne Simon; Pierre-Marie Girard; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml.
AIDS (London, England) 2011;25(3):341-4.
2010: Slim Fourati; Isabelle Malet; Mawuena Binka; Stephanie Boukobza; Marc Wirden; Sophie Sayon; Anne Simon; Christine Katlama; Viviana Simon; Vincent Calvez; Anne-Geneviève Marcelin
Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals.
AIDS (London, England) 2010;24(15):2313-21.
2009: Marc Wirden; Anne Simon; Luminita Schneider; Roland Tubiana; Isabelle Malet; Hocine Ait Mohand; Gilles Peytavin; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug.
The Journal of antimicrobial chemotherapy 2009;64(5):1087-90.
2009: Cathia Soulié; Roland Tubiana; Anne Simon; Sidonie Lambert-Niclot; Isabelle Malet; Ana Canestri; Christel Brunet; Robert Murphy; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):60-4.
2009: Marc Wirden; Roland Tubiana; F Marguet; I Leroy; Anne Simon; Manuela Bonmarchand; Zaina Ait-Arkoub; R Murphy; Anne-Geneviève Marcelin; Christine Katlama; Vincent Calvez
Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.
Journal of clinical microbiology 2009;47(5):1543-5.
2008: Cathia Soulié; Isabelle Malet; Sidonie Lambert-Niclot; Roland Tubiana; Monique Thévenin; Anne Simon; Robert Murphy; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients.
AIDS (London, England) 2008;22(16):2212-4.
2008: Isabelle Malet; Cathia Soulie; Luba Tchertanov; Anne Derache; Bahia Amellal; Ousmane Traore; Anne Simon; Christine Katlama; Jean-François Mouscadet; Vincent Calvez; Anne-Geneviève Marcelin
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases.
Journal of medical virology 2008;80(5):754-61.
2008: Cathia Soulié; Anne Derache; C Aimé; Anne-Geneviève Marcelin; Guislaine Carcelain; Anne Simon; Christine Katlama; Vincent Calvez
Comparison of two genotypic algorithms to determine HIV-1 tropism.
HIV medicine 2008;9(1):1-5.
2007: Isabelle Malet; Marc Wirden; Anne Derache; Anne Simon; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients.
AIDS (London, England) 2007;21(7):871-3.
2007: Isabelle Malet; Bénédicte Roquebert; Cécile Dalban; Marc Wirden; Bahia Amellal; Rachid Agher; Anne Simon; Christine Katlama; Dominique Costagliola; Vincent Calvez; Anne-Geneviève Marcelin
Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
The Journal of infection 2007;54(4):367-74.
2007: Bénédicte Roquebert; Marc Wirden; Anne Simon; Jérome Deval; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre-treated HIV infected patients.
Journal of medical virology 2007;79(3):207-11.
2007: Anne Derache; Ousmane Traore; Victoria Koita; Aliou Sylla; Roland Tubiana; Anne Simon; Ana Canestri; Guislaine Carcelain; Christine Katlama; Vincent Calvez; Mamadou Cisse; Anne-Geneviève Marcelin
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Antiviral therapy 2007;12(1):123-9.
2006: Aurelie Schnuriger; Stephanie Dominguez; Marc-Antoine Valantin; Roland Tubiana; Claudine Duvivier; Jade Ghosn; Anne Simon; Christine Katlama; Vincent Thibault
[Early detection of hepatitis C virus infection using a new combined antigen-antibody detection assay: potential use in HIV co-infected individuals].
Pathologie-biologie 2006;54(10):578-86.
2006: Murielle Mary-Krause; Eric Billaud; Isabelle Poizot-Martin; Anne Simon; Catherine Dhiver; Caroline Dupont; Dominique Salmon; Laurent Roudiere; Dominique Costagliola
Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.
AIDS (London, England) 2006;20(12):1627-35.
2006: Marc Wirden; Bénédicte Roquebert; Anne Derache; Anne Simon; Claudine Duvivier; Jade Ghosn; Stephanie Dominguez; Véronique Boutonnet; Zaina Ait-Arkoub; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients.
Antimicrobial agents and chemotherapy 2006;50(7):2553-6.
2006: Stephanie Dominguez; Jade Ghosn; Marc-Antoine Valantin; Aurélie Schruniger; Anne Simon; Philippe Bonnard; Eric Caumes; Gilles Pialoux; Yves Benhamou; Vincent Thibault; Christine Katlama
Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
AIDS (London, England) 2006;20(8):1157-61.
2006: Aurelie Schnuriger; Stephanie Dominguez; Marc-Antoine Valantin; Roland Tubiana; Claudine Duvivier; Jade Ghosn; Anne Simon; Christine Katlama; Vincent Thibault
Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals.
Journal of clinical microbiology 2006;44(4):1561-3.
2006: Bénédicte Roquebert; Isabelle Malet; Marc Wirden; Roland Tubiana; Marc-Antoine Valantin; Anne Simon; Christine Katlama; Gilles Peytavin; Vincent Calvez; Anne-Geneviève Marcelin
Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors.
AIDS (London, England) 2006;20(2):287-9.
2005: Roland Tubiana; Guislaine Carcelain; Muriel Vray; Karine Gourlain; Cécile Dalban; Aziza Chermak; Claire Rabian; Daniel Vittecoq; Anne Simon; Elisabeth Bouvet; Raphaelle El Habib; Dominique Costagliola; Vincent Calvez; Brigitte Autran; Christine Katlama
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).
Vaccine 2005;23(34):4292-301.
2005: Marc Wirden; Anne-Geneviève Marcelin; Anne Simon; Myriam Kirstetter; Roland Tubiana; Marc-Antoine Valantin; Luc Paris; Manuela Bonmarchand; Francoise Conan; Laurence Kalkias; Christine Katlama; Vincent Calvez
Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.
Journal of medical virology 2005;76(3):297-301.
2005: Marc Wirden; Isabelle Malet; Anne Derache; Anne-Geneviève Marcelin; Bénédicte Roquebert; Anne Simon; Myriam Kirstetter; Laurence Morand Joubert; Christine Katlama; Vincent Calvez
Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitution.
AIDS (London, England) 2005;19(6):630-2.
2005: Jade Ghosn; Marguerite Guiguet; Claude Jardel; Rabah Benyaou; Valérie Zeller; Anne Simon; Marc-Antoine Valantin; Bahia Amellal; Lambert Assoumo; Jean-Yves Hogrel; Dominique Costagliola; Christine Katlama; Anne Lombès
Muscle and liver lactate metabolism in HAART-treated and naive HIV-infected patients: the MITOVIR study.
Antiviral therapy 2005;10(4):543-50.
2004: Philippe Bossi; Gilles Peytavin; Hocine Ait Mohand; Constance Delaugerre; Nadine Ktorza; Luc Paris; Manuela Bonmarchand; R Cacace; D-J David; Anne Simon; Claire Lamotte; Anne-Geneviève Marcelin; Vincent Calvez; François Bricaire; Dominique Costagliola; Christine Katlama
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
HIV medicine 2004;5(5):352-9.
2004: Jade Ghosn; S Pierre-François; Vincent Thibault; Claudine Duvivier; Roland Tubiana; Anne Simon; Marc-Antoine Valantin; Stephanie Dominguez; Eric Caumes; Christine Katlama
Acute hepatitis C in HIV-infected men who have sex with men.
HIV medicine 2004;5(4):303-6.
2004: Anne-Geneviève Marcelin; Constance Delaugerre; Marc Wirden; Pedro Viegas; Anne Simon; Christine Katlama; Vincent Calvez
Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure.
Journal of medical virology 2004;72(1):162-5.
2003: Marc Wirden; Anne Simon; Luminita Schneider; Roland Tubiana; Luc Paris; Anne-Geneviève Marcelin; Constance Delaugerre; Mayeule Legrand; Serge Herson; Gilles Peytavin; Christine Katlama; Vincent Calvez
Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIs.
Journal of clinical microbiology 2003;41(6):2713-5.
2003: Anne-Geneviève Marcelin; Claire Lamotte; Constance Delaugerre; Nadine Ktorza; Hocine Ait Mohand; Raquel Cacace; Manuela Bonmarchand; Marc Wirden; Anne Simon; Philippe Bossi; François Bricaire; Dominique Costagliola; Christine Katlama; Gilles Peytavin; Vincent Calvez
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2003;47(2):594-600.
2002: Vincent Calvez; Dominique Costagliola; Diane Descamps; Anne Yvon; Gilles Collin; Agnès Cécile; Constance Delaugerre; Florence Damond; Anne-Geneviève Marcelin; Sophie Matheron; Anne Simon; Marc-Antoine Valantin; Christine Katlama; Françoise Brun-Vézinet
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.
Antiviral therapy 2002;7(3):211-8.
2001: Constance Delaugerre; Marc-Antoine Valantin; Mireille Mouroux; Manuela Bonmarchand; Guislaine Carcelain; Claudine Duvivier; Roland Tubiana; Anne Simon; François Bricaire; Henri Agut; Brigitte Autran; Christine Katlama; Vincent Calvez
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.
AIDS (London, England) 2001;15(16):2189-91.
2001: Constance Delaugerre; R Rohban; Anne Simon; Mireille Mouroux; C Tricot; Rachid Agher; Jean-Marie Huraux; Christine Katlama; Vincent Calvez
Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.
Journal of medical virology 2001;65(3):445-8.
2001: Constance Delaugerre; Mireille Mouroux; A Yvon-Groussin; Anne Simon; F Angleraud; Jean-Marie Huraux; Henri Agut; Christine Katlama; Vincent Calvez
Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice.
Antimicrobial agents and chemotherapy 2001;45(3):946-8.